Rhumbline Advisers Reduces Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Rhumbline Advisers trimmed its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 1.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 172,071 shares of the biopharmaceutical company’s stock after selling 3,263 shares during the […]
More Stories
Gifto (GTO) Price Tops $0.0171 on Exchanges
Gifto (GTO) traded down 2% against the U.S. dollar during the one day period ending at 16:00 PM ET on...
SPX6900 Reaches 24-Hour Trading Volume of $21.31 Million (SPX)
SPX6900 (SPX) traded 4.5% lower against the US dollar during the 24-hour period ending at 16:00 PM ET on October...
Huobi BTC Achieves Market Capitalization of $43.61 Million (HBTC)
Huobi BTC (HBTC) traded 8.3% lower against the US dollar during the 1 day period ending at 16:00 PM Eastern...
Beldex Price Up 3% Over Last 7 Days (BDX)
Beldex (BDX) traded 0.4% lower against the US dollar during the 1-day period ending at 16:00 PM ET on October...
Art de Finance (ADF) One Day Trading Volume Tops $5,766.30
Art de Finance (ADF) traded down 0.5% against the dollar during the 1-day period ending at 16:00 PM ET on...
ABBC Coin Price Hits $0.0062 on Exchanges (ABBC)
ABBC Coin (ABBC) traded 0.4% lower against the US dollar during the twenty-four hour period ending at 17:00 PM ET...